Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where P. Dazzan is active.

Publication


Featured researches published by P. Dazzan.


European Psychiatry | 2015

High Potency Cannabis Affects Corpus Callosum (CC) Microstructural Organization

S. Rigucci; T. Reis Marques; M. Di Forti; Heather Taylor; Flavio Dell'Acqua; Valeria Mondelli; Stefania Bonaccorso; Andrew Simmons; Anthony S. David; Paolo Girardi; Carmine M. Pariante; R.M. Murray; P. Dazzan

Introduction High potency cannabis has been associated with greater risk, and earlier onset of psychosis. However, its effect on brain structure, particularly white matter (WM), has never been explored. Objectives and Aims To elucidate the interplay between cannabis potency, pattern of use (frequency and age of first use) and CC microstructure; in patients with first-episode psychosis (FEP) and healthy controls. Methods 56 FEP and 43 healthy controls underwent Diffusion-Tensor Imaging combined with WM mapping-tractography. CC was virtually dissected and segmented to calculate Fractional Anisotropy (FA), Mean Diffusivity (MD), Axial Diffusivity (AD) and Radial Diffusivity (RD) for each CC segment. Results High potency cannabis users had higher Total CC MD and Total CC AD than both low potency users and those who never used (p=0.009 and p=0.02 respectively). Daily users also had higher Total CC MD and Total CC AD than both occasional users and those who never used (p=0.02 and p=0.01 respectively). Furthermore, daily/highpotency users had higher Total CC MD than those who never used or used weekly [F(2,57)=4.7, p=0.01]. There was no effect of diagnosis or diagnosis X potency/patterns of use interactions; neither differences between users who started before the age of 15 and those who started later were detected, in any diffusivity measures. Conclusions Frequent use of high-potency cannabis significantly affects callosal microstructure, regardless of the presence of a psychotic disorder. Given the increased availability and use of high potency preparations in Europe, raising awareness about some of their detrimental effects is an important avenue to pursue.


British Journal of Psychiatry | 2006

Grey matter correlates of minor physical anomalies in the AESOP first-episode psychosis study

Kimberlie Dean; Paul Fearon; Kevin Morgan; Gerard Hutchinson; K. Orr; Xavier Chitnis; John Suckling; R. Mallet; Julian Leff; Peter B. Jones; Robin M. Murray; P. Dazzan


Schizophrenia Bulletin | 2011

PATHWAYS TO SCHIZOPHRENIA: THE IMPACT OF SOCIAL DISADVANTAGE IN CHILDHOOD

Simona A. Stilo; Craig Morgan; M. Di Forti; Alessandra Paparelli; Jennifer O'Connor; Manuela Russo; Ben Wiffen; Candice Joseph; Miriam Sirianni; Lucia Sideli; Sonija Luzi; Sonia Pintore; Anna Kolliakou; C. Pariante; P. Dazzan; Clare Flach; R.M. Murray


Schizophrenia Research | 2006

TC4E CHILDHOOD MALTREATMENT AS A RISK FACTOR FOR PSYCHOSIS.

Helen L. Fisher; C. Morgan; Paul Fearon; Kevin Morgan; P. Dazzan; G. Doody; Tom Craig; Glynn Harrison; Julian Leff; Philip H. Jones; R.M. Murray


Schizophrenia Research | 2006

Symptom dimensions and ethnicity in the AESOP first onset psychosis study

Arsime Demjaha; Kevin Morgan; C. Morgan; P. Dazzan; Sabine Landau; Kimberlie Dean; Paul Fearon; Julian Leff; Philip H. Jones; Robin M. Murray


Schizophrenia Research | 2008

2 – The association between minor physical anomalies and IQ in first episode psychosis

B. Dimambro; Tuhina Lloyd; P. Dazzan; Kimberlie Dean; Paul Fearon; G. Doody; Jane Tarrant; Kevin Morgan; C. Morgan; Gerard Hutchinson; Julian Leff; Glynn Harrison; R.M. Murray; Peter B. Jones


Schizophrenia Research | 2006

WC11C SOCIAL EXPERIENCE, ETHNICITY AND PSYCHOSIS

C. Morgan; James B. Kirkbride; Julian Leff; Tom Craig; Gerard Hutchinson; Kwame McKenzie; Kevin Morgan; P. Dazzan; G. Doody; Philip H. Jones; R.M. Murray; Paul Fearon


European Neuropsychopharmacology | 2005

P.3.17 Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the ÆSOP study

P. Dazzan; K.D. Morgan; K. Orr; G. Hutchinson; X. Chitnis; John Suckling; P. Fearon; Philip McGuire; R.M. Mallett; Peter B. Jones; J. Leff; Robin M. Murray


Schizophrenia Research | 2004

Psychopathological dimensions in the AESOP first onset psychosis study

Arsime Demjaha; Kevin Morgan; P. Dazzan; N Kennedy; Kimberlie Dean; B Chapple; Paul Fearon; R Mallett; Julian Leff; Robin M. Murray


Schizophrenia Research | 2002

Neuroanatomical correlates of neurological soft signs: The Aesop first-onset psychosis study

P. Dazzan; Kevin Morgan; John Suckling; Xavier Chitnis; Kenneth G. Orr; Paul Fearon; G Hutchison; J. Salvo; Ben Chapple; Philip H. Jones; R Mallett; Julian Leff; Robin M. Murray

Collaboration


Dive into the P. Dazzan's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kevin Morgan

University of Nottingham

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

M. Di Forti

University of Cambridge

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gerard Hutchinson

University of the West Indies

View shared research outputs
Top Co-Authors

Avatar

G. Doody

University of Nottingham

View shared research outputs
Researchain Logo
Decentralizing Knowledge